T Cell Lymphoma Treatment – Non-Hodgkin Lymphoma

T Cell Lymphoma Treatment – Non-Hodgkin Lymphoma

For my T Cell Lymphoma treatment, I had 2 cycles of Hyper-CVAD chemo. Hyper-CVAD is a common chemo regimen. After receiving this, I underwent stem cell transplant.

T Cell Lymphoma Treatment - Non-Hodgkin Lymphoma

T Cell Lymphoma Treatment – Chemotherapy

I received the following doses of chemo

Drug Name Route Cumulative Dose
Vincristine IV 3.6 mg/m2
Dexamethasone Oral 640 mg/m2
Doxorubicin IV 100 mg/m2
Cyclophosphamide IV 6600 mg/m2
Methotrexate (high dose) IV 2000 mg/m2
Cytarabine (high dose) IV 24,000 mg/m
Cytarabine Spinal tap 70 mg
Methotrexate Spinal tap 84 mg
Carmustine IV 450 mg/m2
Etoposide IV 1800 mg/m2

 

Surgery

I had the following surgical procedures as part of my treatment:

  • May 14, 2004: Hickman catheter placement (central line) by Vijay Trisal, MD at City of Hope
  • September 22, 2004: Hickman removal by R. David Sanders, PA-C at City of Hope

Autologous Hematopoietic Stem Cell Transplantation

Autologous Hematopoietic Stem Cell Transplantation
Autologous Hematopoietic Stem Cell Transplantation

I received a stem cell transplantation as part of my treatment for T Cell Lymphoblastic Lymphoma.  My blood stem cells were collected and then put back into my body after I was treated with chemo. My infusion date was September 8, 2004, therefore I consider it my 2nd birthday.

Treatment Complications

Chemotherapy was discontinued because of a decrease in my cardiac function during my bone marrow transplant.

Last updated: July 10th, 2017